Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06745245Not ApplicableActive Not Recruiting

Effect of Oral Consumption of a Symbiotic Gelatin on the Presence of Gastrointestinal Symptoms and Quality of Life in People With Chronic Kidney Disease

Role: lead

NCT06576479Not ApplicableRecruiting

Effect of a Specialized Oral Supplement on Nutritional Status and Quality of Life in Non-dialysis CKD

Role: lead

NCT06738550Not ApplicableEnrolling By Invitation

Effect of Agave Inulin on Constipation and Quality of Life in Peritoneal Dialysis Patients.

Role: lead

All 3 trials loaded